The Tisch Cancer Institute

TCI Supported Research Facilities

Over the past three years, The Tisch Cancer Institute (TCI) has allocated funds for the development of both a Human Immune Monitoring Center and a Hematological Malignancies Tissue Bank

The Human Immune Monitoring Center was identified as a critical service for enhancing research in cancer immunotherapies, a major focus of the Cancer Immunology program. 

Most recently, TCI has initiated the development of a Vaccine and Cell Therapy Facility. This new facility represents another critical service for research in cancer immunotherapies and functions synergistically with the Human Immune Monitoring Center.